Starpharma Holdings LimitedASX: SPL

Starpharma commences phase 1/2 DEP irinotecan trial

Aug 8, 2019 at 3:29 AM UTC · Issued by Starpharma Holdings Limited

Starpharma Holdings Ltd has released a press release.

View Attachment